share_log

Connect Biopharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%), etc.

康乃德生物 | SC 13G/A:超过5%持股股东披露文件(修正)-Qiming Corporate GP V, Ltd(5.8%),Qiming GP V, L.P.(5.6%)等

2023/02/14 06:27
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息